These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy]. Kołodziejczyk M, Kępka L, Tyc-Szczepaniak D, Wierzchowski M. Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256 [Abstract] [Full Text] [Related]
4. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation. Haidar YM, Rahn DA, Nath S, Song W, Bazhenova L, Makani S, Fuster MM, Sandhu AP. Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338 [Abstract] [Full Text] [Related]
9. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Baumann P, Nyman J, Lax I, Friesland S, Hoyer M, Rehn Ericsson S, Johansson KA, Ekberg L, Morhed E, Paludan M, Wittgren L, Blomgren H, Lewensohn R. Acta Oncol; 2006 Aug; 45(7):787-95. PubMed ID: 16982541 [Abstract] [Full Text] [Related]
11. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry. Davis JN, Medbery C, Sharma S, Pablo J, Kimsey F, Perry D, Muacevic A, Mahadevan A. Radiat Oncol; 2015 May 15; 10():113. PubMed ID: 25975848 [Abstract] [Full Text] [Related]
12. Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure. Andratschke N, Zimmermann F, Boehm E, Schill S, Schoenknecht C, Thamm R, Molls M, Nieder C, Geinitz H. Radiother Oncol; 2011 Nov 15; 101(2):245-9. PubMed ID: 21724287 [Abstract] [Full Text] [Related]